On Thursday 21 March, we held an event at the V&A in Dundee to thank 45 volunteer lifestyle coaches for their involvement in the pioneering...

26 March 2019

PARP inhibitors are a type of targeted therapy currently used to treat BRCA-mutated ovarian cancer and have been approved for treatment of advanced...

11 March 2019

Trisha McAneny, 44 from Erskine is calling on women and men who have been through breast cancer to apply to be the People’s Postcode Lottery...

4 March 2019

Sir Mike, who was the NHS’ first cancer director and is the former CQC chief inspector of hospitals, is leading a review team to assess current...

21 February 2019

In final draft guidance, NICE has approved Perjeta – given in combination with trastuzumab and chemotherapy – as a new option after surgery for some...

15 February 2019

Our research has provided strong evidence that women aged 35-39 at a moderate or high risk of developing breast cancer, could benefit from annual...

11 February 2019

A leading Manchester scientist has been awarded a prestigious fellowship by Breast Cancer Now to investigate whether targeting two key proteins could...

4 February 2019

Two leading Bradford scientists have been awarded a combined total of more than £280,000 by research charity Breast Cancer Now, to develop a new type...

4 February 2019

Researchers part-funded by Breast Cancer Now have identified changes in breast cancer cells that could in future help predict the likelihood of...

21 January 2019